The PARTNER II Trial: Placement of AoRTic TraNscathetER Valves - PII B

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 560 participants.

Also called NCT02184442

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 560 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02184442
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02184442. Randomized; no masking; primary purpose treatment. Start 2011-03-09 (actual); primary completion 2013-05-01 (actual). Results posted on 2018-08-14.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
The PARTNER II Trial: Placement of AoRTic TraNscathetER Valves - PII B
Acronym
PARTNERII B
Condition
Severe
Condition
Symptomatic
Condition
Calcific Aortic Stenosis
Intervention (Device)
TAVR Implantation with SAPIEN XT
Intervention (Device)
TAVR Implantation with SAPIEN
Lead sponsor
Edwards Lifesciences (class: industry)
Collaborator
American College of Cardiology (class: other)

Record details

Record id
cardio:ct-nct02184442
Content hash
aeec2654026983505ae6996e498f3d7a6411fa3193f0129cee03a5ca9bca84c6